Hypophosphatasia Europe is proud to announce that it will organize and sponsor the Sixth International Symposium on alkaline phosphatases (APs) and hypophosphatasia (HPP). This will be the second time that basic researchers, physicians and advocacy group members gather in Huningue, France, to discuss the latest information pertaining to the function of APs and therapies being developed for the management of AP-associated disorders.
The previous symposium in 2007 witnessed the announcement of the first successful pre-clinical trials of enzyme replacement therapy for HPP in mice. Since then, clinical trials of life-threatening HPP have been completed with remarkable results and phase II/III clinical trials on HPP patients with adult disease have been initiated. This upcoming Symposium will highlight the wealth of clinical data that has been obtained on the management of HPP patients, while also discussing new information about other pathophysiological conditions related to alterations in AP structure and function.
We look forward to welcoming you in Huningue in 2012 for four days of intense scientific and personal interactions while enjoying the hospitality of the dedicated volunteers of “Hypophosphatasia Europe”, a public not-for-profit organization that aims to gather and disseminate information on APs to help patients with HPP and their families.
Steve Ursprung (Huningue, France) – President of Hypophosphatasie Europe
Agnès Bloch-Zupan (Strasbourg, France)
Etienne Mornet (Versailles, France)